Remission and recovery and their predictors in schizophrenia spectrum disorder: Results from a 1-year follow-up naturalistic trial

Psychiatric Quarterly

Volumn 83, Issue 2, 2012, Pages 187-207

  Schennach, Rebecca ^a   Riedel, Michael ^a,b   Obermeier, Michael ^a   Jäger, Markus ^a   Schmauss, Max ^c   Laux, Gerd ^d   Pfeiffer, Herbert ^e   Naber, Dieter ^f   Schmidt, Lutz G ^g   Gaebel, Wolfgang ^h   Klosterkötter, Joachim ⁱ   Heuser, Isabella ^j   Maier, Wolfgang ^k   Lemke, Matthias R ^l   Rüther, Eckart ^m   Klingberg, Stefan ⁿ   Gastpar, Markus ^o   Seemüller, Florian ^a   Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Vinzenz von Paul Hospital   (Germany)

^c District Hospital   (Germany)

^d Inn Salzach Hospital   (Germany)

^e KLINIKUM MÜNCHEN OST   (Germany)

^f UNIVERSITY OF HAMBURG   (Germany)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k UNIVERSITY OF BONN   (Germany)

^l Alsterdorf Hospital   (Germany)

^m UNIVERSITY OF GÖTTINGEN   (Germany)

ⁿ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^o UNIVERSITY OF DUISBURG ESSEN   (Germany)

more..

Author keywords

1 year follow up; Predictors; Recovery; Remission; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CONVALESCENCE; DEMOGRAPHY; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTOR VARIABLE; REMISSION; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AFTERCARE; AGED; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; FRIENDS; GERMANY; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PATIENT DISCHARGE; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL PARTICIPATION; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84863983421     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-011-9193-z     Document Type: Article

References (47)

1. Bellack AS: Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophrenia Bulletin 32:432-442, 2006.
2. Leucht S, Lasser R: The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39:161-170, 2006.
3. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162:441-449, 2005.
4. Liberman R, Kopelowicz A, Ventura J, Gutkind D: Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry 4:256-272, 2002.
5. Emsley R, Chiliza B, Schoeman R: Predictors of long-term outcome in schizophrenia. Current Opinion in Psychiatry 21:173-177, 2008.
6. Menezes NM, Arenovich T, Zipursky RB: A systematic review of longitudinal outcome studies of firstepisode psychosis. Psychological Medicine 36:1349-1362, 2006.
7. Wolwer W, Buchkremer G, Hafner H, Klosterkotter J, Maier W, Moller HJ, Gaebel W: German research network on schizophrenia-bridging the gap between research and care. European Archives of Psychiatry and Clinical Neuroscience 253:321-329, 2003.
8. Jager M, Riedel M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Kuhn KU, Lemke MR, Ruther E, Buchkremer G, Gastpar M, Bottlender R, Strauss A, Moller HJ: Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. European Archives of Psychiatry and Clinical Neuroscience 257: 47-53, 2007.
9. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC, American Psychiatric Association, 1994.
10. Cording C: Conceptual aspects in development and implementation of basic psychiatric documentation. Psychiatrische Praxis 25:175-178, 1998.
11. Kay SR, Opler LA, Lindenmayer JP: Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Research 23:99-110, 1988.
12. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23:56-62, 1960.
13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd Rev edn. Washington DC, American Psychiatric Association, 1987.
14. Naber D: A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. International Clinical Psy-chopharmacology 10(Suppl 3):133-138, 1995.
15. Phillips L: Case history data and prognosis in schizophrenia. Journal of Nervous and Mental Disease 515-525, 1953.
16. Weinstein MC, Fineberg HV: Clinical decisions analysis. Philadelphia, PA, WB Saunders, 1980.
17. R Development Core Team. A language and environment for statistical computing. URL http://www. R-project.org. 2008. Vienna, Austria, Foundation for Statistical Computing. Ref Type: Computer Program.
18. Jager M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Kuhn KU, Lemke MR, Ruther E, Buchkremer G, Gastpar M, Bottlender R, Strauss A, Moller HJ: Prediction of symptom remission in schizophrenia during inpatient treatment. World Journal of Biological Psychiatry 1-9, 2007.
19. Beitinger R, Lin J, Kissling W, Leucht S: Comparative remission rates of schizophrenic patients using various remission criteria. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32: 1643-1651, 2008.
20. San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I: Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. European Psychiatry 22:490-498, 2007.
21. Alptekin K, Erkoc S, Gogus AK, Kultur S, Mete L, Ucok A, Yazici KM: Disability in schizophrenia: clinical correlates and prediction over 1-year follow-up. Psychiatry Research 135:103-111, 2005.
22. Bobes J, Ciudad A, Alvarez E, San L, Polavieja P, Gilaberte I: Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission. Schizophrenia Research 115:58-66, 2009.
23. Novick D, Haro JM, Suarez D, Vieta E, Naber D: Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study. Schizophrenia Research 108: 223-230, 2009.
24. Faerden A, Nesvag R, Marder SR: Definitions of the term 'recovered' in schizophrenia and other disorders. Psychopathology 41:271-278, 2008.
25. Wobrock T, Kohler J, Klein P, Falkai P: Achieving symptomatic remission in out-patients with schizophrenia-a naturalistic study with quetiapine. Acta Psychiatrica Scandinavica 120:120-128, 2009.
26. Brousse G, Meary A, Blanc O, Lancon C, Llorca PM, Leboyer M: Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia. Psychiatry Research 179:12-18, 2010.
27. Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD: Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophrenia Research 119:1-10, 2010.
28. Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW, Schimmelmann BG: Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatrica Scandinavica 118:220-229, 2008.
29. Crespo-Facorro B, Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, Llorca J, Luis Vazquez-Barquero J: A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. Journal of Clinical Psychiatry 67:1511-1521, 2006.
30. Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van H, I, Eerdekens M, Swyzen W, De SG: Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. American Journal of Psychiatry 162:947-953, 2005.
31. Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, Bartzokis G, Aravagiri M: Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. American Journal of Psychiatry 158:1835-1842, 2001.
32. Perkins D, Lieberman J, Gu H, Tohen M, McEvoy J, Green A, Zipursky R, Strakowski S, Sharma T, Kahn R, Gur R, Tollefson G: Predictors of antipsychotic treatment response in patients with firstepisode schizophrenia, schizoaffective and schizophreniform disorders. British Journal of Psychiatry 185:18-24, 2004.
33. Haro JM, Novick D, Suarez D, Ochoa S, Roca M: Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:1287-1292, 2008.
34. Haro JM, Novick D, Suarez D, Alonso J, Lepine JP, Ratcliffe M: Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study. Journal of Clinical Psychopharmacology 26:571-578, 2006.
35. De HM, van WR, Wampers M, Kane J, Van OJ, Peuskens J: Remission criteria for schizophrenia: evaluation in a large naturalistic cohort. Schizophrenia Research 92:68-73, 2007.
36. Lindenmayer JP, Liu-Seifert H, Kulkarni PM, Kinon BJ, Stauffer V, Edwards SE, Chen L, Adams DH, scher-Svanum H, Buckley PF, Citrome L, Volavka J: Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. Journal of Clinical Psychiatry 70:990-996, 2009.
37. Ciudad A, Alvarez E, Bobes J, San L, Polavieja P, Gilaberte I: Remission in schizophrenia: Results from a 1-year follow-up observational study. Schizophrenia Research 108:214-222, 2009.
38. Malla A, Norman R, Schmitz N, Manchanda R, Bechard-Evans L, Takhar J, Haricharan R: Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychological Medicine 36:649-658, 2006.
39. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, Green AI, Glick IB, Kahn RS, Sharma T, Tohen M, McEvoy JP, Weiden PJ, Lieberman JA: Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophrenia Research 83:53-63, 2006.
40. Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in schizophrenia: its validity, frequency, predictors and patients' perspective 5 years after. Dialogues in Clinical Neuroscience 2010 (in press).
41. Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW: Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. European Archives of Psychiatry and Clinical Neuroscience 256:246-255, 2006.
42. Wittorf A, Wiedemann G, Buchkremer G, Klingberg S: Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. European Archives of Psychiatry and Clinical Neuroscience 258:48-58, 2008.
43. Marwaha S, Johnson S: Schizophrenia and employment\-a review. Social Psychiatry and Psychiatric Epidemiology 39:337-349, 2004.
44. Boardman J, Grove B, Perkins R, Shepherd G: Work and employment for people with psychiatric disabilities. British Journal of Psychiatry 182:467-468, 2003.
45. Kilian R, Matschinger H, Becker T, Angermeyer MC: A longitudinal analysis of the impact of social and clinical characteristics on the costs of schizophrenia treatment. Acta Psychiatrica Scandinavica 107:351-360, 2003.
46. Rund BR: Fully recovered schizophrenics: a retrospective study of some premorbid and treatment factors. Psychiatry 1990;53:127-139.
47. Hafner H, an der HW: The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. European Archives of Psychiatry and Clinical Neuroscience 249(Suppl 4):14-26, 1999.